Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AMA wants to import cheap prices

WASHINGTON - The American Medical Association's House of Delegates passed resolutions about parallel imports of pharmaceuticals and about genetically modified foods at the association's interim meeting in San Diego last week.

The delegates resolved that the AMA's "Council

Read the full 383 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE